Catalent
CTLT
#1585
Rank
S$14.18 B
Marketcap
$78.15
Share price
-0.18%
Change (1 day)
18.50%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total debt

Total debt on the balance sheet as of June 2024 : S$6.40 B

According to Catalent's latest financial reports the company's total debt is S$6.40 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Catalent - Total debt on balance sheet (from 2013 to 2024)

Total debt by year

Year Total debt Change
2023-06-30S$6.57 B12.2%
2022-06-30S$5.85 B33.66%
2021-06-30S$4.38 B3.65%
2020-06-30S$4.22 B5.6%
2019-06-30S$4.00 B7.94%
2018-06-30S$3.70 B29.55%
2017-06-30S$2.86 B14.09%
2016-06-30S$2.50 B-0.87%
2015-06-30S$2.53 B-25.28%
2014-06-30S$3.38 B-0.67%
2013-06-30S$3.41 B0.31%
2012-06-30S$3.40 B

Total debt for similar companies or competitors

Company Total debt differencediff. Country
S$52.07 M-99.19%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.43 B-93.15%๐Ÿ‡บ๐Ÿ‡ธ USA
S$7.54 B 17.76%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
S$0.29 B-95.45%๐Ÿ‡บ๐Ÿ‡ธ USA